Better rolls out a poison pill as Garg fights for control

Better, a company operating in the real estate and property sector, has adopted a shareholder rights plan, commonly referred to as a "poison pill," in an effort to prevent a potential takeover by activist investor Garg. This move comes as Garg is seeking to gain control of the company. The plan will be triggered if Garg or any other entity acquires 15% or more of Better's outstanding shares or voting power, making it more difficult and expensive for Garg to gain control.

The adoption of the poison pill by Better is significant in the context of the architecture and real estate industries, where companies often face pressure from investors seeking to influence their strategic direction. In the architecture sector, companies are frequently involved in large-scale projects that require significant investment and planning. A change in control could potentially disrupt these projects and impact the company's relationships with clients, architects, and contractors. The poison pill plan will remain in effect until 2027, giving Better's management team time to focus on executing their business strategy without the immediate threat of a hostile takeover.

Looking ahead, industry stakeholders should watch how this development affects Better's relationships with its investors, clients, and partners in the architecture and real estate sectors. Additionally, it will be important to see how Garg responds to the adoption of the poison pill and whether the activist investor will attempt to negotiate with Better's management team or pursue other strategies to achieve their goals. The outcome of this situation could have implications for the broader real estate and property industry, particularly in terms of corporate governance and the balance of power between management teams and activist investors.

Originally reported by housingwire.com. ArchitectureNews adds analysis for real estate & property readers.